相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The hallmarks of cancer metabolism: Still emerging
Natalya N. Pavlova et al.
CELL METABOLISM (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Glutamine promotes escape from therapy-induced senescence in tumor cells
Francesco Pacifico et al.
AGING-US (2021)
Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization
Anna Mukha et al.
AUTOPHAGY (2021)
A proteomic investigation of isogenic radiation resistant prostate cancer cell lines
Natalie Kurganovs et al.
PROTEOMICS CLINICAL APPLICATIONS (2021)
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
Anna Mukha et al.
THERANOSTICS (2021)
Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer
Joseph Sia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance
Varintra E. Krisnawan et al.
CANCERS (2020)
Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open-Cancer Horizons roundtable discussion
Patrick W. Burke et al.
ESMO OPEN (2020)
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
Manabu Kato et al.
ONCOGENE (2019)
Treatment of Advanced Prostate Cancer
Min Yuen Teo et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Development and characterisation of acquired radioresistant breast cancer cell lines
Mark Gray et al.
RADIATION ONCOLOGY (2019)
Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer
Junfeng Zhang et al.
BIOSCIENCE REPORTS (2019)
Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway
Konjeti R. Sekhar et al.
PLOS ONE (2019)
SLC1A3 contributes to L-asparaginase resistance in solid tumors
Jianhui Sun et al.
EMBO JOURNAL (2019)
Glutamine Addiction and Therapeutic Strategies in Lung Cancer
Karolien Vanhove et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long-lived Myc hypomorphic mice
Xiaoai Zhao et al.
AGING CELL (2019)
R2: Genomics analysis and visualization platform
Jan Koster et al.
CANCER RESEARCH (2019)
Effects of glutamine deprivation on oxidative stress and cell survival in breast cell lines
Mokgadi Violet Gwangwa et al.
BIOLOGICAL RESEARCH (2019)
Multiple Severe Toxicities of L-Asparaginase and Their Innovative Management during Induction Therapy of Acute Lymphoblastic Leukemia in an Adult Patient
Guillaume Beziat et al.
CASE REPORTS IN HEMATOLOGY (2019)
Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoring
Marta Barrado et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2019)
Antagonizing CD105 enhances radiation sensitivity in prostate cancer
Anisha Madhav et al.
ONCOGENE (2018)
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming
Rajeev Mishra et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
W. U. Shipley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells
H. Takahashi et al.
ONCOGENE (2017)
Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia
Jamie Koprivnikar et al.
ONCOTARGETS AND THERAPY (2017)
The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer
Brock J. Sishc et al.
CANCERS (2017)
A Comprehensive Review on L-Asparaginase and Its Applications
Tahira Batool et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2016)
Effects of L-Glutamine oral supplementation on prostate of irradiated rats
Flavia C. M. Pinto et al.
INTERNATIONAL BRAZ J UROL (2016)
Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells
N. McDermott et al.
SCIENTIFIC REPORTS (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
Decai Yu et al.
ONCOTARGET (2015)
Hedgehog Signaling Drives Radioresistance and Stroma-Driven Tumor Repopulation in Head and Neck Squamous Cancers
Gregory N. Gan et al.
CANCER RESEARCH (2014)
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Christopher T. Hensley et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Radical Radiotherapy for High-Risk Prostate Cancer in Older Men
Heather A. Payne et al.
ONCOLOGIST (2012)
Genome-wide DNA Methylation Events in TMPRSS2-ERG Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with miR-26a Hypermethylation
Stefan T. Boerno et al.
CANCER DISCOVERY (2012)
Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness
X. Li et al.
ONCOGENE (2011)
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
Jian-Bin Wang et al.
CANCER CELL (2010)
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Ping Gao et al.
NATURE (2009)
Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations - The past, the present and recommendations for the future
VI Avramis et al.
CLINICAL PHARMACOKINETICS (2005)
分享论文
